SLC6A1 has been linked to autosomal dominant myoclonic-atonic epilepsy (MAE, [MIM: 616421]) and was recently implicated in a novel disease, SLC6A1-related neurodevelopmental disorders. Here, SLC6A1 is linked to neurodevelopmental disorder.